首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Shugang Qin,Hai Huang,Wen Xiao,Kepan Chen,Xi He,Xiaoshan Tang,Zhiying Huang,Yupei Zhang,Xing Duan,Na Fan,Qian Zheng,Min Wu,Guangwen Lu,Yuquan Wei,Xiawei Wei,Xiangrong Song(Department of Critical Care Medicine,Frontiers Science Center for Disease-related Molecular Network,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University).A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Xiaosen Ouyang1,Willayat Y.Wani1,Gloria A.Benavides1,Matthew J.Redmann1,Hai Vo1,Thomas van Groen2,Victor M.Darley-Usmar1,Jianhua Zhang1,3(Department of Pathology,University of Alabama at Birmingham;Department of Cell,Developmental and Integrative Biology,University of Alabama at Birmingham;Birmingham VA Medical Center,University of Alabama at Birmingham).Cathepsin D overexpression in the nervous system rescues lethality and Aβ42 accumulation of cathepsin D systemic knockout in vivo[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Shuai Shao,Chengjuan Chen,Gaona Shi,Yu Zhou,Yazi Wei,Lei Wu,Lan Sun,Tiantai Zhang(State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences&Peking Union Medical College).JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Dejuan Sun1,Yuanyuan Guo1,Piyu Tang1,Hua Li1,2,Lixia Chen1(Wuya College of Innovation,Key Laboratory of Structure-Based Drug Design&Discovery,Ministry of Education,Shenyang Pharmaceutical University;College of Pharmacy,Fujian University of Traditional Chinese Medicine).Arf6 as a therapeutic target:Structure,mechanism, and inhibitors[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Zhijia Wang1,2,Hanxuan Li3,Lantu Gou1,Wei Li3,Yuxi Wang1,2(Department of Pulmonary and Critical Care Medicine,Targeted Tracer Research and Development Laboratory,Institute of Respiratory Health,Frontiers Science Center for Disease-related Molecular Network,National Clinical Research Center for Geriatrics,State Key Laboratory of Biotherapy,Precision Medicine Key Laboratory of Sichuan Province&Precision Medicine Research Center,West China Hospital,Sichuan University;Frontiers Medical Center,Tianfu Jincheng Laboratory;Department of Pharmaceutical Sciences,College of Pharmacy,University of Tennessee Health Science Center).Antibody-drug conjugates:Recent advances in payloads[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Yu Zhang1,Ruizhe Huang1,Yunchun Jiang1,Wenhao Shen1,Hailong Pei1,Guanglin Wang1,Pei Pei2,Kai Yang1(State Key Laboratory of Radiation Medicine and Protection,School of Radiation Medicine and Protection&School for Radiological and Interdisciplinary Sciences(RAD-X),Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,Soochow University;Teaching and Research Section of Nuclear Medicine,School of Basic Medical Sciences,Anhui Medical University).The role of bacteria and its derived biomaterials in cancer radiotherapy[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Li-Long Pan1,Zheng-Nan Ren2,3,Jun Yang4,Bin-Bin Li2,3,Yi-Wen Huang2,3,Dong-Xiao Song2,3,Xuan Li2,3,Jia-Jia Xu5,Madhav Bhatia6,Duo-Wu Zou7,Chun-Hua Zhou7,Jia Sun2,3(Wuxi Medical School,Jiangnan University;School of Food Science and Technology,Jiangnan University;State Key Laboratory of Food Science and Resources,Jiangnan University;Department of General Surgery,Affiliated Hospital of Jiangnan University;Department of General Medicine,Beicai Community Health Service Center of Pudong New District;Department of Pathology,University of Otago;Department of Gastroenterology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine).Gut microbiota controls the development of chronic pancreatitis:A critical role of short-chain fatty acids-producing Gram-positive bacteria[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Cancan Zheng1,Xiaomei Yu1,Taoyang Xu1,Zhichao Liu2,Zhili Jiang3,Jiaojiao Xu1,Jing Yang1,Guogeng Zhang1,Yan He1,Han Yang4,Xingyuan Shi3,Zhigang Li2,Jinbao Liu5,Wen Wen Xu5(Key Laboratory of Biological Targeting Diagnosis,Therapy and Rehabilitation of Guangdong Higher Education Institutes,the Fifth Affiliated Hospital of Guangzhou Medical University;Department of Thoracic Surgery,Shanghai Chest Hospital,School of Medicine,Shanghai Jiao Tong University;Department of Radiation Oncology,the Fifth Affiliated Hospital of Guangzhou Medical University;Department of Thoracic Surgery,Sun Yat-sen University Cancer Center;Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,and School of Basic Medical Sciences,Guangzhou Medical University).KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Yuechao Dong,Yangshan Chen,Guixing Ma,Huiling Cao(Department of Biochemistry,School of Medicine,Southern University of Science and Technology,Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research,Key University Laboratory of Metabolism and Health of Guangdong).The role of E3 ubiquitin ligases in bone homeostasis and related diseases[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Yang Liu1,2,Xiaowei Zhang1,2,Ping Zhang1,2,Tingting He1,2,Weitao Zhang1,2,Dingyuan Ma,Ping Li1,Jun Chen1,2(State Key Laboratory of Natural Medicines,China Pharmaceutical University;Department of Pharmacognosy,School of Traditional Chinese Pharmacy,China Pharmaceutical University;Department of Prenatal Diagnosis,Nanjing Maternity and Child Health Care Hospital,Women’s Hospital of Nanjing Medical University).A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Yixin Chen1,2,Mei-Juan Tu1,Fangwei Han3,Zhenzhen Liu1,Neelu Batra1,Primo N.Lara4,Hong-Wu Chen1,Huichang Bi2,Ai-Ming Yu1(Department of Biochemistry and Molecular Medicine,School of Medicine,UC Davis;School of Pharmaceutical Sciences,Sun Yat-sen University;School of Public Health,UNT Health Science Center;Department of Internal Medicine,School of Medicine,UC Davis).Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Tong Gao,Xiao Sang,Xinyan Huang,Panpan Gu,Jie Liu,Yongjun Liu,Na Zhang(Department of Pharmaceutics,Key Laboratory of Chemical Biology(Ministry of Education),NMPA Key Laboratory for Technology Research and Evaluation of Drug Products,School of Pharmaceutical Sciences,Cheeloo College of Medicine,Shandong University).Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Jiao Zhang1,Qian Luo1,Qian Hu1,Tiantian Zhang1,Jingyu Shi2,Li Kong1,Dehao Fu3,Conglian Yang1,Zhiping Zhang1,4,5(Tongji School of Pharmacy,Huazhong University of Science and Technology;Liyuan Hospital of Tongji Medical College of Huazhong University of Science and Technology;Department of Orthopaedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine;National Engineering Research Center for Nanomedicine,Huazhong University of Science and Technology;Hubei Engineering Research Center for Novel Drug Delivery System,Huazhong University of Science and Technology).An injectable bioactive dressing based on platelet-rich plasma and nanoclay:Sustained release of deferoxamine to accelerate chronic wound healing[J].Acta Pharmaceutica Sinica B,2023,第10期
  • Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang(Zhejiang Province Key Laboratory of Anti-Cancer Drug Research;Department of Medical Thoracic Oncology;Department of Gastrointestinal Surgery;The Innovation Institute for Artificial Intelligence in Medicine;Cancer Center of Zhejiang University).Author correction to“Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA'[Acta Pharmaceutica Sinica B 13(2023)2585-2600][J].药学学报(英文版),2023,第10期
  • Xueqin Huang,Bingbing Sheng,Hemi Tian,Qiuxia Chen,Yingqi Yang,Brian Bui,Jiang Pi,Huaihong Cai,Shanze Chen,Jianglin Zhang,Wei Chen,Haibo Zhou,Pinghua Sun(The Second Clinical Medical College(Shenzhen People's Hospital);Department of Chemistry;Department of Physics).Author correction to‘Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy'[Acta Pharm Sin B 13(2023)1303-1317)[J].药学学报(英文版),2023,第10期
  • Ling Ye1,Shicheng Fan1,Pengfei Zhao2,Chenghua Wu1,Menghua Liu1,Shuang Hu1,Peng Wang1,Hongyu Wang1,Huichang Bi1(NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Sciences,Southern Medical University;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,School of Pharmaceutical Sciences,Sun Yat-sen University).Potential herb-drug interactions between anti-COVID-19 drugs and traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Liming Gong1,2,Heming Zhao1,2,Yanhong Liu1,2,Hao Wu3,Chao Liu1,2,Shuangyan Chang1,2,Liqing Chen1,2,Mingji Jin1,2,Qiming Wang1,2,Zhonggao Gao1,2,Wei Huang1,2(State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations,Department of Pharmaceutics,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Pharmacy,Yanbian University).Research advances in peptide-drug conjugates[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Dandong Fang1,2,3,Yu Li1,2,Bo He1,2,Daqian Gu1,2,Mingming Zhang1,2,Jingwen Guo1,2,Hongmei Ren1,2,Xinyue Li1,2,Ziyue Zhang1,2,Ming Tang1,2,Xingbing Li1,2,Donghai Yang1,2,Chunmei Xu1,2,Yijie Hu4,Hongyong Wang1,2,Pedro A.Jose5,Yu Han1,2,Chunyu Zeng1,2,6,7(Department of Cardiology,Daping Hospital,the Third Military Medical University (Army Medical University);Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research,Ministry of Education of China,Chongqing Key Laboratory for Hypertension Research,Chongqing Cardiovascular Clinical Research Center,Chongqing Institute of Cardiology;Department of Critical Care Medicine,Jinling Hospital,Affiliated Hospital of Medical School,Nanjing University;Department of Cardiac Surgery,Daping Hospital,Third Military Medical University;Division of Renal Disease & Hypertension,the George Washington University School of Medicine & Health Sciences;State Key Laboratory of Trauma,Burns and Combined Injury,Daping Hospital,the Third Military Medical University;Cardiovascular Research Center of Chongqing College,Chinese Academy of Sciences,University of Chinese Academy of Sciences).Gastrin attenuates sepsis-induced myocardial dysfunction by down-regulation of TLR4 expression in macrophages[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Yanze Sun1,2,3,Xinmiao Yu1,2,3,Xiao Wang1,2,3,Kai Yuan1,2,3,Gefei Wang1,2,3,Lingrong Hu1,2,3,Guoyu Zhang1,2,3,Wenli Pei1,2,3,Liping Wang1,2,3,Chengliang Sun1,2,3,Peng Yang1,2,3(State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University;Institute of Innovative Drug Discovery and Development,China Pharmaceutical University).Bispecific antibodies in cancer therapy:Target selection and regulatory requirements[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Hao Tian1,2,Juanfeng Ou1,Yong Wang2,Jia Sun1,Junbin Gao1,Yicheng Ye1,Ruotian Zhang1,Bin Chen1,Fei Wang1,Weichang Huang1,Huaan Li1,2,Lu Liu1,Chuxiao Shao,Zhili Xu4,Fei Peng5,Yingfeng Tu1,2(NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Sciences,Southern Medical University;Department of Pharmacy,Zhujiang Hospital,Southern Medical University;Key Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui,Central Laboratory of Lishui People’s Hospital,The Sixth Affiliated Hospital of Wenzhou Medical University;Department of Ultrasound,Institute of Ultrasound in Musculoskeletal Sports Medicine,Guangdong Second Provincial General Hospital;School of Materials Science and Engineering,Sun Yat-Sen University).Bladder microenvironment actuated proteomotors with ammonia amplification for enhanced cancer treatment[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Hongjuan Zhao1,2,3,Yatong Li1,Beibei Zhao1,Cuixia Zheng1,2,Mengya Niu1,Qingling Song1,Xinxin Liu4,5,Qianhua Feng1,2,Zhenzhong Zhang1,2,Lei Wang1,2,5(School of Pharmaceutical Sciences,Zhengzhou University;Key Laboratory of Advanced Pharmaceutical Technology,Ministry of Education of China,Zhengzhou University;Biotherapy Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou University;Luoyang Central Hospital Affiliated to Zhengzhou University;Tumor Immunity and Biomaterials Advanced Medical Center,Zhengzhou University).Orchestrating antigen delivery and presentation efficiency in lymph node by nanoparticle shape for immune response[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Yalan Wang1,Qiubing Chen2,3,Shuang Wu1,Xinyu Sun1,Runting Yin1,Zhen Ouyang1,Hao Yin2,3,4,5,6,Yuan Wei1(School of Pharmacy,Jiangsu University;Department of Urology,Frontier Science Centre for Immunology and Metabolism,Medical Research Institute,Zhongnan Hospital of Wuhan University,Wuhan University;Department of Pulmonary and Critical Care Medicine,Zhongnan Hospital of Wuhan University;Department of Pathology,Zhongnan Hospital of Wuhan University;RNA Institute,Wuhan University;Wuhan Research Centre for Infectious Diseases and Cancer,Chinese Academy of Medical Sciences).Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Jiafan Yang1,2,Zhenbin Zhou1,2,Yingying Chen1,Yongxiang Song1,2,Jianhua Ju1,2(CAS Key Laboratory of Tropical Marine Bio-resources and Ecology,RNAM Center for Marine Microbiology,Guangdong Key Laboratory of Marine Materia Medica,South China Sea Institute of Oceanology,Chinese Academy of Sciences;University of Chinese Academy of Sciences).Characterization of the depsidone gene cluster reveals etherification, decarboxylation and multiple halogenations as tailoring steps in depsidone assembly[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Xin Tang1,2,Chuanxi Wang3,Lei Wang4,5,Feifei Ren2,Runqiao Kuang3,Zhenhua Li1,2,Xue Han3,Yiming Chen2,Guodong Chen3,Xiuqing Wu2,Jie Liu4,Hengwen Yang2,Xingzhong Liu6,Chen Wang4,Hao Gao3,Zhinan Yin1,2(Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Institute of Translational Medicine,Zhuhai People's Hospital Affiliated with Jinan University,Jinan University;Biomedical Translational Research Institute,Health Science Center (School of Medicine),Jinan University;Institute of Traditional Chinese Medicine and Natural Products,College of Pharmacy/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China,Jinan University;Department of Respirology,Capital Medical University;Department of Respiratory and Critical Care Medicine,the Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital);State Key Laboratory of Mycology,Institute of Microbiology,Chinese Academy of Sciences).Aureane-type sesquiterpene tetraketides as a novel class of immunomodulators with interleukin-17A inhibitory activity[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Mei Lu1,2,Haonan Xing2,3,Wanxuan Shao1,Pengfei Wu1,Yuchuan Fan1,Huining He4,Stefan Barth5,Aiping Zheng3,Xing-Jie Liang2,Yuanyu Huang1(Advanced Research Institute of Multidisciplinary Science,School of Life Science,School of Medical Technology,Key Laboratory of Molecular Medicine and Biotherapy,Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering,Beijing Institute of Technology;Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China;State Key Laboratory of Toxicology and Medical Countermeasures,Beijing Institute of Pharmacology and Toxicology;Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics,School of Pharmacy,Tianjin Medical University;South African Research Chair in Cancer Biotechnology,Institute of Infectious Disease and Molecular Medicine(IDM),Department of Integrative Biomedical Sciences,Faculty of Health Sciences,University of Cape Town).Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Huiwen Liu1,Honglan Wang1,Qiyu Li2,Yiwei Wang1,Ying He3,Xuejing Li3,Chunyan Sun1,Onder Ergonul4,Füsun Can4,Zhiqing Pang3,Bo Zhang1,Yu Hu1(Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science & Technology;Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai Institute of Cardiovascular Diseases;School of Pharmacy,Fudan University,Key Laboratory of Smart Drug Delivery,Ministry of Education;Koc University Is Bank Center for Infectious Diseases (KUISCID),Lnfectious Diseases and Clinical Microbiology Department,Ko? University School of Medicine and American Hospital).LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Thuy Giang Nguyen Cao1,Ji Hee Kang2,Su Jin Kang1,Quan Truong Hoang1,Han Chang Kang3,Won Jong Rhee1,4,Yu Shrike Zhang,Young Tag Ko2,Min Suk Shim1(Division of Bioengineering,Incheon National University;College of Pharmacy,Gachon University;Department of Pharmacy,Integrated Research Institute of Pharmaceutical Sciences,and BK21 PLUS Team for Creative Leader Program for Pharmacomics-based Future Pharmacy,College of Pharmacy,the Catholic University of Korea;Research Center for Bio Materials & Process Development,Incheon National University;Division of Engineering in Medicine,Department of Medicine,Brigham and Women’s Hospital,Harvard Medical School).Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood-brain barrier[J].Acta Pharmaceutica Sinica B,2023,第9期
  • Chen Li1,2,Jiayan Lang1,2,Yazhou Wang3,Zhaoxia Cheng1,4,Mali Zu1,2,Fenfen Li1,5,Jingyi Sun1,2,Yating Deng1,2,Tianjiao Ji1,2,Guangjun Nie1,2,Ying Zhao1,2(CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety,CAS Center of Excellence in Nanoscience,National Center for Nanoscience and Technology;Center of Materials Science and Optoelectronics Engineering,University of Chinese Academy of Sciences;Pancreas Centre,the First Affiliated Hospital of Nanjing Medical University;Green Catalysis Center,and College of Chemistry,Zhengzhou University;School of Basic Medical Sciences,Zhengzhou University).Self-assembly of CXCR4 antagonist peptide-docetaxel conjugates for breast tumor multi-organ metastasis inhibition[J].Acta Pharmaceutica Sinica B,2023,第9期
首页 上一页 1 2 3 4 5 下一页 尾页 共有12页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966